跳至主要内容
临床试验/CTRI/2024/03/063983
CTRI/2024/03/063983尚未招募Unknown

Effect Of SGLT-2 Inhibitor On Indices Of Atrial Myopathy In Rheumatic Mitral Valve Disease - Nil

GOVIND BALLABH PANT INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH NEW DELHI0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • rheumatic mitral valve disease of moderate seviarity includes moderate mitral stenosis/ moderate mitral regurgitation/ combination of both with any of the high risk features in form of48-hour holter monitoring showing paroxysmal /non sustained atrial arrythmia.
  • Trans thoracic echocardiography LA anteroposterior diameter more than 3.5cm.
  • Abnormal LA strain or LAA velocity.
  • LA or LAA smoke.
  • History of transient ischemic attack in past.

排除标准

  • Rheumatic mitral disease requiring intervention/surgery
  • Associated congenital heart disease.
  • Left ventricular systolic dysfunction
  • Associated chronic kidney disease or known coronary artery disease.
  • Pregnancy and lactation.
  • Low quality echocardiographic image.
  • Concomitant aortic stenosis and/or regurgitation .

研究者

发起方
GOVIND BALLABH PANT INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH NEW DELHI

相似试验